Drug intelligence / Profile preview

Xinyi San

Development stage
Preclinical
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Xinyi San is a traditional Chinese medicine (TCM) formula, also known as Magnolia Flower Powder, primarily indicated for the treatment of allergic rhinitis and chronic sinusitis, particularly the "lung qi deficiency and cold" type. The formula is a combination of several botanical ingredients, typically including *Magnolia biondii* (Xinyi), *Angelica dahurica* (Baizhi), and *Mentha haplocalyx* (Bohe), which work synergistically to dispel wind-cold, reduce nasal congestion, and modulate the immune response. Clinical research, such as that conducted by Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, evaluates modified granule formulations of Xinyi San to compare their efficacy and safety against traditional decoctions and standard Western medical treatments.

Other names
Magnolia Flower PowderXinyi PowderXin Yi San
02

Targets

IL-4 (Interleukin 4)IFNG (Interferon gamma)IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Xinyi San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinyi San.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call